Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 34665 | 108 | 31.7 | 50% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 396 | 3 | SYSTEMIC LUPUS ERYTHEMATOSUS//ANTIPHOSPHOLIPID SYNDROME//LUPUS | 30351 |
| 3251 | 2 | NEUROENDOCRINOIMMUNOL//EXPT RHEUMATOL NEUROENDOCRINOIMMUNOL//EVANS IMMUNOL | 1982 |
| 34665 | 1 | DINALINE//ACETYLDINALINE//SEMI ALLOGENEIC | 108 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | DINALINE | authKW | 904757 | 4% | 80% | 4 |
| 2 | ACETYLDINALINE | authKW | 508924 | 3% | 60% | 3 |
| 3 | SEMI ALLOGENEIC | authKW | 318076 | 3% | 38% | 3 |
| 4 | ACETOXYMETHYLMETHYLNITROSAMINE INDUCED COLORECTAL CARCINOMA | authKW | 282737 | 1% | 100% | 1 |
| 5 | CARCINOGENICITY IN RATS | authKW | 282737 | 1% | 100% | 1 |
| 6 | CI 994 STUDIES IN MICE | authKW | 282737 | 1% | 100% | 1 |
| 7 | HEMATOL POB 5201 | address | 282737 | 1% | 100% | 1 |
| 8 | NORMAL STEM CELL | authKW | 282737 | 1% | 100% | 1 |
| 9 | PRECLINICAL ANTITUMOR ACTIVITY | authKW | 282737 | 1% | 100% | 1 |
| 10 | REDUCED INCIDENCE OF MALIGNANCIES | authKW | 282737 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Oncology | 1444 | 59% | 0% | 64 |
| 2 | Hematology | 1354 | 34% | 0% | 37 |
| 3 | Medicine, Research & Experimental | 95 | 12% | 0% | 13 |
| 4 | Immunology | 34 | 10% | 0% | 11 |
| 5 | Cell Biology | 16 | 8% | 0% | 9 |
| 6 | Pharmacology & Pharmacy | 14 | 9% | 0% | 10 |
| 7 | Biology | 12 | 4% | 0% | 4 |
| 8 | Cell & Tissue Engineering | 9 | 1% | 0% | 1 |
| 9 | Radiology, Nuclear Medicine & Medical Imaging | 8 | 5% | 0% | 5 |
| 10 | Transplantation | 5 | 2% | 0% | 2 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | HEMATOL POB 5201 | 282737 | 1% | 100% | 1 |
| 2 | STROM THURMOND BIOMED | 70683 | 1% | 25% | 1 |
| 3 | EXPTL GERONTOL | 56546 | 1% | 20% | 1 |
| 4 | 8621 | 40389 | 1% | 14% | 1 |
| 5 | RECH VITRY | 40389 | 1% | 14% | 1 |
| 6 | RADIOLIGAND | 13462 | 1% | 5% | 1 |
| 7 | HAEMATOL L | 12291 | 1% | 4% | 1 |
| 8 | MED PHARMAZEUT CHEM | 12291 | 1% | 4% | 1 |
| 9 | U496 | 12291 | 1% | 4% | 1 |
| 10 | PATHOL EXPT TOXICOL | 8076 | 1% | 3% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | LEUKEMIA RESEARCH | 10545 | 14% | 0% | 15 |
| 2 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 3750 | 5% | 0% | 5 |
| 3 | LEUKEMIA | 3032 | 8% | 0% | 9 |
| 4 | INTERNATIONAL JOURNAL OF CELL CLONING | 2614 | 2% | 0% | 2 |
| 5 | GENETICA POLONICA | 1691 | 1% | 1% | 1 |
| 6 | JOURNAL OF IMMUNOTHERAPY | 1509 | 3% | 0% | 3 |
| 7 | JOURNAL OF TRANSLATIONAL MEDICINE | 1095 | 3% | 0% | 3 |
| 8 | INVESTIGATIONAL NEW DRUGS | 993 | 3% | 0% | 3 |
| 9 | ANNALES DE L INSTITUT PASTEUR-IMMUNOLOGY | 907 | 1% | 0% | 1 |
| 10 | EXPERIMENTAL HEMATOLOGY | 788 | 4% | 0% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | RIVA, L , BLANEY, SM , DAUSER, R , NUCHTERN, JG , DURFEE, J , MCGUFFEY, L , BERG, SL , (2000) PHARMACOKINETICS AND CEREBROSPINAL FLUID PENETRATION OF CI-994 (N-ACETYLDINALINE) IN THE NONHUMAN PRIMATE.CLINICAL CANCER RESEARCH. VOL. 6. ISSUE 3. P. 994-997 | 9 | 100% | 14 |
| 2 | MARTENS, ACM , VANBEKKUM, DW , HAGENBEEK, A , (1990) THE BN ACUTE MYELOCYTIC-LEUKEMIA (BNML) (A RAT MODEL FOR STUDYING HUMAN ACUTE MYELOCYTIC-LEUKEMIA (AML)).LEUKEMIA. VOL. 4. ISSUE 4. P. 241-257 | 28 | 33% | 44 |
| 3 | ELBELTAGI, HM , MARTENS, ACM , LELIEVELD, P , HAROUN, EA , HAGENBEEK, A , (1993) ACETYLDINALINE - A NEW ORAL CYTOSTATIC DRUG WITH IMPRESSIVE DIFFERENTIAL ACTIVITY AGAINST LEUKEMIC-CELLS AND NORMAL STEM-CELLS - PRECLINICAL STUDIES IN A RELEVANT RAT MODEL FOR HUMAN ACUTE MYELOCYTIC-LEUKEMIA.CANCER RESEARCH. VOL. 53. ISSUE 13. P. 3008-3014 | 9 | 82% | 32 |
| 4 | MC CORMACK, E , BRUSERUD, O , GJERTSEN, BT , (2005) ANIMAL MODELS OF ACUTE MYELOGENOUS LEUKAEMIA - DEVELOPMENT, APPLICATION AND FUTURE PERSPECTIVES.LEUKEMIA. VOL. 19. ISSUE 5. P. 687-706 | 37 | 11% | 42 |
| 5 | ELBELTAGI, HM , MARTENS, ACM , HAROUN, EA , HAGENBEEK, A , (1993) IN-VIVO DEVELOPMENT OF AN ACETYLDINALINE RESISTANT SUBLINE OF THE BN RAT ACUTE MYELOCYTIC-LEUKEMIA (BNML).LEUKEMIA. VOL. 7. ISSUE 8. P. 1275-1280 | 6 | 100% | 2 |
| 6 | ELBELTAGI, HM , MARTENS, ACM , DAHAB, GM , HAGENBEEK, A , (1993) EFFICACY OF ACETYLDINALINE FOR TREATMENT OF MINIMAL RESIDUAL DISEASE (MRD) - PRECLINICAL STUDIES IN THE BNML RAT MODEL FOR HUMAN ACUTE MYELOCYTIC-LEUKEMIA.LEUKEMIA. VOL. 7. ISSUE 11. P. 1795 -1800 | 7 | 78% | 9 |
| 7 | KINDY, MS , YU, J , ZHU, H , SMITH, MT , GATTONI-CELLI, S , (2016) A THERAPEUTIC CANCER VACCINE AGAINST GL261 MURINE GLIOMA.JOURNAL OF TRANSLATIONAL MEDICINE. VOL. 14. ISSUE . P. - | 5 | 42% | 0 |
| 8 | LORUSSO, PM , DEMCHIK, L , FOSTER, B , KNIGHT, J , BISSERY, MC , POLIN, LM , LEOPOLD, WR , CORBETT, TH , (1996) PRECLINICAL ANTITUMOR ACTIVITY OF CI-994.INVESTIGATIONAL NEW DRUGS. VOL. 14. ISSUE 4. P. 349 -356 | 5 | 63% | 28 |
| 9 | RUMMEL, SA , KRAKER, AJ , STEINKAMPF, RW , HOOK, KE , KLOHS, WD , (1995) ROLE OF A SMALL MOLECULAR-WEIGHT PHOSPHOPROTEIN IN THE MECHANISM OF ACTION OF CI-994 (N-ACETYLDINALINE).INTERNATIONAL JOURNAL OF CANCER. VOL. 62. ISSUE 5. P. 636-642 | 6 | 55% | 12 |
| 10 | YU, J , KINDY, MS , GATTONI-CELLI, S , (2007) SEMI-ALLOGENEIC VACCINE FOR T-CELL LYMPHOMA.JOURNAL OF TRANSLATIONAL MEDICINE. VOL. 5. ISSUE . P. - | 6 | 38% | 0 |
Classes with closest relation at Level 1 |